-+ 0.00%
-+ 0.00%
-+ 0.00%

UROGEN PHARMA - UGN-501 EXPECTED TO BEGIN PHASE 1 TRIAL IN Q4 2026

路透·08/05/2026 12:00:03

登录查看新闻详情